Life sciences news
-
Biocartis announces planned operational reorganization and cost reduction program
Friday June 16th 2023
Read more
-
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
Friday June 16th 2023
Read more
-
Mithra announces new positive preclinical data from CSF-1R inhibitor program
Thursday June 15th 2023
Read more
-
My Pathomation new release at the ECDP
Wednesday June 14th 2023
Read more
-
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
Tuesday June 13th 2023
Read more
-
ΛCTIV by Aphea.Bio® launched in Poland
Monday June 12th 2023
Read more
-
Oxurion finalizes enrollment in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema
Monday June 12th 2023
Read more
-
SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance
Wednesday June 7th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more
-
Biotalys continues to demonstrate strength of first biocontrol in latest global field trials
Friday June 2nd 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
